Every Cure is deeply grateful to Giorgos Tsetis for his partnership and generous donation to our mission.

Giorgos Tsetis, Nutrafol CEO and founder, turned a personal challenge into a transformative mission. After battling hair loss and harsh treatment side effects, he engineered a new approach to hair wellness that is now trusted by millions. Under his leadership, Nutrafol became the #1 dermatologist-recommended brand and was successfully acquired by Unilever.

“I’m profoundly grateful that Nutrafol succeeded, not just because it created financial upside, but because it created perspective,” Tsetis said. “It gave me the space to zoom out and ask: Where can I actually help? What suffering can we reduce? What futures can we unlock?

Philanthropy, for me, isn’t a side project or a reputation move. It’s the most honest use of the leverage I have been given — capital, relationships, and lived lessons — to turn success into something that genuinely matters.”

In 2025, Tsetis launched his family office, Great Things™, with the goal of using his investment profits to fund philanthropy. “At Great Things, we don’t back organizations as structures — we back people as forces for change. We look for leaders with a deeply personal connection to the problem, because conviction outlasts obstacles; we look for approaches that challenge assumptions and go after root causes, because repeating the same model produces the same outcomes; and we look for proximity to the truth — teams close to patients and real-world feedback — because impact only happens when strategy stays grounded in reality.”

Soon after launching Great Things, Tsetis made a generous $1 million donation to Every Cure. “What drew me to Every Cure,” he said, “is that it goes after the gap the system often leaves behind: rare diseases, overlooked patients, and promising uses of existing drugs that don’t fit traditional incentives. Pharma and the broader system aren’t consistently rewarded for pursuing what’s possible — they are rewarded for pursuing what’s profitable. But suffering doesn’t care about incentives, and neither should we.”

“Dr. David Fajgenbaum’s story is a big part of why this is so real to me,” he continued. “He didn’t come to this work from a distance — he came to it from the inside. He lived the stakes personally, fought for his own life, and turned that experience into a mission to help others who are suffering and too often left without answers. That level of authenticity and determination is rare, and it’s exactly the kind of leadership that can carry a hard problem further than ‘good intentions’ ever could.”

“Every Cure is practical and deeply humane: it’s focused on finding solutions that may already be within reach, and using AI to accelerate discovery in a way that’s never been possible before. That combination — existing medicine, modern intelligence, and moral clarity — can move faster for people who’ve been left in the dark for far too long.”